Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

Chicagoland research labs and community clinics are navigating illegal funding stoppages, censorship, and increasing ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The heads of national HIV organizations have stepped up their advocacy, asking Congress to oppose cuts in President Donald ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

To compensate for tax cuts for the wealthy, Trump’s 'big, beautiful' bill and budget proposal for fiscal year 2026 threaten to curtail Medicaid, which provides health coverage for people with low ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

The rates of new HIV infections in Houston and Harris County are higher than the national average. National HIV Testing Day is Friday, June 27th and it's a great reminder to get tested and know your ...

The administration’s proposed budget for HIV prevention represents a 78 percent reduction compared to last fiscal year.